News

Johnson Matthey Faces Setback with Disappointing H1 Performance

Johnson Matthey Faces Setback with Disappointing H1 Performance

Johnson Matthey Faces Setback with Disappointing H1 Performance

Shares of Johnson Matthey (LON:JMAT) took a notable plunge following the release of the company's results for the first half of fiscal 2025. A decline of 4.5% was observed, raising concerns among investors about the company's financial health as it fell short of market expectations.

Weaker Than Anticipated Results

Johnson Matthey reported an underlying EBIT of £156 million, marking a significant 13% decrease year-over-year. This figure was not only below the company's previous year performance but also 13% less than the consensus estimate of £179 million, indicating a tough environment for their operations.

Sales Performance

Total sales, excluding metal, registered at £1,722 million. This represents a 3% drop compared to the previous year and is 7% lower than what analysts had projected, which was set at £1,860 million. This sales shortfall signals potential difficulties in demand within the company's markets.

Division Performance Insights

Breaking down the figures revealed that the PGM Services and Value Businesses divisions bore the brunt of the earnings miss. The PGM Services division, in particular, experienced an alarming 35% drop in EBIT, landing at £51 million—far from the £74 million expected. Contributing factors included reduced auto scrap volumes and lower metal recovery rates.

Value Business Challenges

In the Value Businesses division, EBIT fell sharply to just £2 million, an 86% decrease from the prior year. The closure of the Medical Device Components business has clearly impacted this sector.

Some Positive Highlights

In contrast to the struggles faced in other areas, the Clean Air division delivered EBIT of £121 million, only 2% lower than last year and very close to expectations. This slight underperformance was mitigated by stringent cost-saving efforts. Additionally, Catalyst Technologies stood out, with EBIT increasing by 43% to £50 million—significantly over the anticipated £40 million—driven by higher average prices and strong demand, particularly in China.

Challenges in Hydrogen Technologies

The Hydrogen Technologies division reported an EBIT loss of £26 million, aligning with projections but exceeding expectations of a £21 million deficit. The confidence in the division remains, as the company anticipates reaching a break-even point by FY26, despite ongoing hurdles.

Financial Health Review

The cash flow situation raised eyebrows, with free cash flow showing an outflow of £149 million, compared to the previous year’s £97 million. This worsening situation was attributed to declining profitability, a substantial working capital outflow, and increased capital expenditures.

Dividend Announcement and Future Guidance

Despite these challenges, Johnson Matthey announced an interim dividend of 22p per share, consistent with the previous year’s payout. Additionally, the company reaffirmed its fiscal 2025 guidance, anticipating at least mid-single-digit EBIT growth, excluding the Value Businesses. However, they acknowledged the potential impact of foreign exchange fluctuations and metal prices, which could reduce earnings by around £13 million.

Path Forward

Johnson Matthey indicated that their cost-saving initiatives are progressing well, with £155 million of the targeted £200 million already achieved. With collective strategies in place, management expressed optimism for stronger profitability in the latter part of the fiscal year. They expect to benefit from increased volumes, improved metal recoveries, and ongoing transformation projects.

Outlook for FY25

For the second half of FY25, the company suggested an EBIT of approximately £255 million, which would indicate a 12% increase from the previous year and surpass the consensus estimate of £235 million. While this projection reflects management’s confidence in recovery, analysts highlight that realizing these expectations will depend on improvements in the PGM Services division and effective implementation of cost-saving measures.

Frequently Asked Questions

What are the main reasons for Johnson Matthey's share drop?

The share drop can be attributed to weaker-than-expected results, particularly in the PGM Services and Value Businesses divisions, leading to lower EBIT and sales.

What is the current EBIT for Johnson Matthey?

Johnson Matthey reported an underlying EBIT of £156 million for the first half of fiscal 2025, which is a 13% decline from the previous year.

What challenges is Johnson Matthey facing?

The company is facing challenges such as reduced scrap volumes, lower metal recovery rates, and declining profitability which has impacted cash flow.

How does the company plan to improve its financial position?

They plan to improve their financial position through cost-saving initiatives, with £155 million already achieved, and by aiming for stronger profitability in the second half of the year.

What is the outlook for the second half of FY25?

Johnson Matthey anticipates an EBIT of approximately £255 million for the second half of FY25, indicating a 12% year-over-year increase and exceeding pre-results consensus expectations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 2

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
Tech Breakthroughs in Cancer and Space Energy Aired

Updated Category News Views 3

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Continue Reading
Aluminum Refractory Market to Hit $2.73B by 2031

Updated Category News Views 5

Riding the Aluminum Refractory Wave to 2031 Look, when you want to throw some cash in a market that's gaining steam, aluminum refractory materials might not be your first pick. But here's the thing: it's charging ahead to a cool $2.73 billion by 2031. And if you're keeping tabs on the likes of RHI Magnesita and Calderys, this is a sector that deserves a once-over. What...

Continue Reading
Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Updated Category News Views 2

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Continue Reading
Jixingfeng Advances Smart Manufacturing for Socks Market

Updated Category News Views 3

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Continue Reading
Six Flags Offers Flexible Payment Plan with Flex Pay

Updated Category News Views 6

New Payment Option Brings Flexibility Seems like Six Flags isn't just about roller coasters anymore—now they're playing the long game with wallet-friendly options. Flex Pay by Upgrade is the latest spin on season pass financing, letting guests divvy up payments and kickstart their amusement park fun right away. This move could be a game-changer for folks looking to lock...

Continue Reading
Insurance 101: Know Your Limits and Deductibles

Updated Category News Views 5

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

Continue Reading
Moonlock: Award-Winning Design Elevates Cybersecurity's Importance

Updated Category News Views 2

Design Excellence Meets Cybersecurity There's a new sheriff in town when it comes to cybersecurity design, and its name is Moonlock. MacPaw's antivirus and protection app pulled off a coup by bagging the 2026 Red Dot Award in the Interface & User Experience Design category. It's a big deal in the cybersecurity realm, where functionality often overshadows finesse. But...

Continue Reading
Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 2

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading

Top 5 Most Recently Viewed Articles

Men Finding New Confidence Through Hair Transplant Journeys

Updated Category News Views 152

Men Discovering Renewed Confidence Through Hair Transplant Journeys In recent times, a notable trend has emerged among British men who are turning to hair transplant procedures as a means of self-renewal following breakups. This shift from traditional coping mechanisms, such as nightlife escapades or new tattoos, to simpler, yet profound transformations in personal...

Continue Reading
Bausch Health Outlines RED-C Clinical Trial Findings and Future Steps

Updated Category News Views 121

Bausch Health Offers Insight on RED-C Clinical Trials Results Bausch Health Companies Inc. (NYSE: BHC) has shared pivotal insights regarding the global Phase 3 RED-C clinical trials. These studies were notably focused on evaluating amorphous-rifaximin solid soluble dispersion (SSD) for patients grappling with liver cirrhosis, aiming primarily at the prevention of hepatic...

Continue Reading
Packaging Corporation of America Announces Q4 2024 Earnings Call

Updated Category News Views 141

Packaging Corporation of America Earnings Call Details Packaging Corporation of America (NYSE: PKG) is set to hold an important conference call to discuss its operating results for the fourth quarter and full year of 2024. This call will take place on a Wednesday morning, with the exact time scheduled for 9:00 a.m. Eastern Time. Leadership from PCA, led by Mark Kowlzan,...

Continue Reading
STAAR Surgical and Alcon Merger Bid Fails, What's Next?

Updated Category News Views 142

STAAR Surgical Company's Merger Attempt with Alcon STAAR Surgical Company (NASDAQ: STAA) has recently faced a significant setback. On a momentous Tuesday, the company declared that it did not secure the crucial stockholder support required to finalize its merger agreement with Alcon Inc. (NYSE: ALC) during the Special Meeting of Stockholders. End of the Merger Agreement...

Continue Reading
Analysts Predict Growth Potential for Workday Stock WDAY

Updated Category News Views 227

Analysts See Promise in Workday's Future Workday, Inc (NASDAQ: WDAY) is generating positive attention in the financial markets as analysts present a compelling case for its growth potential. According to insights from Bank of America Securities analyst Brad Sills, the company's stock is considered 'undervalued' and positioned for significant growth. With the ongoing...

Continue Reading